Depuis le démarrage de notre activité de  capital - investissement en 1989, nous avons investi dans plus de 310 sociétés réparties dans 40 pays.

Filter by
Sort by
Société Pays Secteur Description Type de deal Date de l'investissement
Genoa, a QoL Healthcare Company Pays US Secteur Santé Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community Type de deal Buyout Date de l'investissement Apr 2015
Mediq Pays Netherlands Secteur Santé Description Global provider of pharmaceuticals, medical devices and related care services Type de deal Public-to-private Date de l'investissement Feb 2013
Grupo Biotoscana Pays Colombia Secteur Santé Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America Type de deal Buyout Date de l'investissement Nov 2011
Laboratorio LKM Pays Argentina Secteur Santé Description One of the leading specialty pharmaceutical manufacturers in Argentina Type de deal Buyout Date de l'investissement Oct 2011
Labormed Pays Romania Secteur Santé Description Romanian pharmaceutical manufacturer and distributor Type de deal Buyout Date de l'investissement Feb 2008
Terapia Pays Romania Secteur Santé Description Romania's largest independent generic pharmaceuticals manufacturer Type de deal Public-to-private Date de l'investissement Aug 2003
Aviagen Pays UK Secteur Santé Description World's leading meat poultry breeding company Type de deal Buyout Date de l'investissement May 2003
Viatris Pays Germany Secteur Santé Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals Type de deal Buyout Date de l'investissement Aug 2002
Fada Pharma Pays Argentina Secteur Santé Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market Type de deal Buyout Date de l'investissement Jan 2001
Tropon Pays Germany Secteur Santé Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) Type de deal Buyout Date de l'investissement Mar 2000
Alcala Farma Pays Spain Secteur Santé Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products Type de deal Growth equity Date de l'investissement Sep 1999
Trinity Pharmaceuticals Pays UK Secteur Santé Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications Type de deal Buyout Date de l'investissement Mar 1997
3i - Implant Innovations Inc. Pays US Secteur Santé Description Manufacturer of dental implants Type de deal Growth equity Date de l'investissement May 1995
Telik Pays US Secteur Santé Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) Type de deal Growth equity Date de l'investissement Nov 1994
Esaote Biomedica Pays Italy Secteur Santé Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment Type de deal Buyout Date de l'investissement Jul 1994
Transcend Therapeutics Pays US Secteur Santé Description Company formed to develop novel pharmaceuticals for the critical-care market Type de deal Growth equity Date de l'investissement Apr 1994

© 2002-2017 Advent International Corporation. All rights reserved